Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Ibanez

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Circulation Research|December 25, 2018
PATJ Low Frequency Variants Are Associated With Worse Ischemic Stroke Functional OutcomeMarina Mola-Caminal, Caty Carrera, Carolina Soriano-Tárraga, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Brain : a Journal of Neurology|February 25, 2022
Multi-ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic strokeLaura Ibanez, Laura Heitsch, Caty Carrera, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Multi-ancestry genetic study in 5,876 patients identifies an association between excitotoxic genes and early outcomes after acute ischemic strokeLaura Ibanez, Laura Heitsch, Caty Carrera, et al.
Research Square|June 5, 2025
GWAS meta-analysis of CSF Alzheimer's disease biomarkers 18,948 individuals reveal novel loci and genes regulating lipid metabolism, brain volume and autophagyCarlos Cruchaga, Jigyasha Timsina, Chenyang Jiang, et al.
Nature Communications|April 21, 2026
GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagyJigyasha Timsina, Chenyang Jiang, Daniel L McCartney, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics ConsortiumFarid Rajabli, Penelope Benchek, Giuseppe Tosto, et al.
Genome Biology|July 17, 2025
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's diseaseFarid Rajabli, Penelope Benchek, Giuseppe Tosto, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Circulation Research|December 25, 2018
PATJ Low Frequency Variants Are Associated With Worse Ischemic Stroke Functional OutcomeMarina Mola-Caminal, Caty Carrera, Carolina Soriano-Tárraga, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Brain : a Journal of Neurology|February 25, 2022
Multi-ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic strokeLaura Ibanez, Laura Heitsch, Caty Carrera, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Multi-ancestry genetic study in 5,876 patients identifies an association between excitotoxic genes and early outcomes after acute ischemic strokeLaura Ibanez, Laura Heitsch, Caty Carrera, et al.
Research Square|June 5, 2025
GWAS meta-analysis of CSF Alzheimer's disease biomarkers 18,948 individuals reveal novel loci and genes regulating lipid metabolism, brain volume and autophagyCarlos Cruchaga, Jigyasha Timsina, Chenyang Jiang, et al.
Nature Communications|April 21, 2026
GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagyJigyasha Timsina, Chenyang Jiang, Daniel L McCartney, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics ConsortiumFarid Rajabli, Penelope Benchek, Giuseppe Tosto, et al.
Genome Biology|July 17, 2025
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's diseaseFarid Rajabli, Penelope Benchek, Giuseppe Tosto, et al.
Pageof 11